Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Formula for treating inflammatory bowel disease

An inflammatory bowel disease and prescription technology, applied in the field of medicine, can solve problems such as large side effects and unsatisfactory effects, and achieve the effects of good therapeutic effect, prolonging human lifespan, and enhancing blood supply.

Inactive Publication Date: 2016-04-06
何松庆
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above-mentioned treatment measures are unsatisfactory and have large side effects. Therefore, it is an urgent task for the medical community to study the etiology of inflammatory bowel disease, find the cause of the disease, and take corresponding treatment measures.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0026] 1. Ginseng 0.3 g, threonine 0.5 g, serine 0.6 g, cysteine ​​0.06 g, vitamin C 50 mg, vitamin E 4 mg, vitamin A 0.1 mg, β-carotene 0.6 mg, made into a chew, 2 per day To 4 times.

[0027] 2. Ginseng 0.15 g, Threonine 0.25 g, Serine 0.3 g, Cysteine ​​0.03 g, Vitamin C 25 mg, Vitamin E 2 mg, Vitamin A 0.05 mg, β-carotene 0.3 mg, made into a chew, 2 per day To 4 times.

[0028] 3. Ginseng 0.3 g, threonine 0.5 g, serine 0.6 g, cysteine ​​0.06 g, vitamin C 50 mg, vitamin E 4 mg, vitamin A 0.1 mg, β-carotene 0.6 mg, made into a containing agent, 2 per day To 4 times.

[0029] 4. Ginseng 0.15 g, Threonine 0.25 g, Serine 0.3 g, Cysteine ​​0.03 g, Vitamin C 25 mg, Vitamin E 2 mg, Vitamin A 0.05 mg, β-carotene 0.3 mg, made into a containing agent, 2 per day To 4 times.

[0030] 5. Ginseng 1 g, threonine 0.5 g, serine 0.6 g, cysteine ​​0.06 g, vitamin C 50 mg, vitamin E 4 mg, vitamin A 0.1 mg, β-carotene 0.6 mg, made into oral preparations, 2 per day To 4 times.

[0031] 6. Ginseng 0.5 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a formula for treating inflammatory bowel disease, and belongs to the field of drugs. The formula consists of ginseng, threonine, serine, cysteine, vitamin C, vitamin E, vitamin A and beta-carotene. The ginseng has functions of enhancing blood supply and oxygen supply of a human body; the threonine, the serine and the cysteine are main constituent parts of mucoprotein; and the vitamin C, the vitamin E, the vitamin A and the beta-carotene have functions of depressing the activity of oxygen radical, eliminating the oxygen radical and protecting body cells. The formula of the invention can provide nutrition, oxygen and raw materials for the generation, renewal and repair of goblet cells and for the secretion of the mucoprotein from the goblet cells to form an intestinal surface mucous layer barrier. The formula of the invention, as an effective formula for treating inflammatory bowel disease, takes significant effects on terminating inflammation, repairing intestinal structure and building the normal intestinal surface mucous layer barrier of the human body.

Description

Technical field [0001] The invention relates to a combination formula of Chinese medicinal materials, amino acids and vitamins for treating inflammatory bowel disease, and belongs to the field of medicines. Background technique [0002] Inflammatory bowel disease (Inflammatory Boweldisease, IBD) is a disease whose etiology and pathogenesis are not yet fully understood. Because the cause and pathogenesis of the disease have not been fully elucidated, people cannot fundamentally prevent or delay the progression of the disease. [0003] Medical immunology believes that the immune system has abnormal recognition and tolerance of antigens, that is, abnormal recognition of microorganisms that normally inhabit the intestines and produce an immune response to cause the disease. Histology and embryology believe that the permeability of the intestinal mucosa is too high, causing a large amount of intestinal antigens to enter the intestinal wall tissue, triggering a long-term immune system r...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/258A61P1/00A61P1/12A61P11/06A61P11/02A61P37/08A61P1/14A61K31/198A61K31/375A61K31/355A61K31/07A61K31/015
CPCA61K9/0053A61K9/0056A61K31/015A61K31/07A61K31/198A61K31/355A61K31/375A61K36/258A61K2300/00
Inventor 何松庆
Owner 何松庆
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com